Diagnostic and therapeutic strategies for small abdominal aortic aneurysms

Nature Reviews Cardiology

Volumn 8, Issue 6, 2011, Pages 338-347

  Klink, Ahmed ^a   Hyafil, Fabien ^b   Rudd, James ^c   Faries, Peter ^a   Fuster, Valentin ^a   Mallat, Ziad ^c   Meilhac, Olivier ^b   Mulder, Willem J M ^a   Michel, Jean Baptiste ^b   Ramirez, Francesco ^a   Storm, Gert ^d   Thompson, Robert ^e   Turnbull, Irene C ^a   Egido, Jesus ^f   Martín Ventura, Jose L ^f   Zaragoza, Carlos ^g   Letourneur, Didier ^b   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b INSERM   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UTRECHT UNIVERSITY   (Netherlands)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CERIVASTATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE; PROPRANOLOL; ROXITHROMYCIN; SIMVASTATIN; TETRACYCLINE;

ABDOMINAL AORTA ANEURYSM; ADD ON THERAPY; ANEURYSM SURGERY; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA INFECTION; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; HUMAN; MEDICAL LITERATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PRIORITY JOURNAL; REVIEW; SMALL ABDOMINAL AORTA ANEURYSM; TREATMENT PLANNING;

AORTIC ANEURYSM, ABDOMINAL; AORTOGRAPHY; CARDIOVASCULAR AGENTS; DIAGNOSTIC IMAGING; ENDOVASCULAR PROCEDURES; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 79957839382     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.1     Document Type: Review

References (118)

1. Lederle, F. A., et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch. Intern. Med. 160, 1425-1430 (2000). (Pubitemid 30327444)
2. Wilmink, T. B., Quick, C. R., Hubbard, C. S. & Day, N. E. The influence of screening on the incidence of ruptured abdominal aortic aneurysms. J. Vasc Surg. 30, 203-208 (1999). (Pubitemid 29395387)
3. Hellenthal, F. A., Buurman, W. A., Wodzig, W. K. & Schurink, G. W. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat. Rev. Cardiol. 6, 464-474 (2009).
4. Hellenthal, F. A., Buurman, W. A., Wodzig, W. K. & Schurink, G. W. Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation. Nat. Rev. Cardiol. 6, 543-552 (2009).
5. Michel, J. B. Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler. Thromb. Vasc. Biol. 21, 1389-1392 (2001).
6. Wang, Y., et al. TGF-beta; activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Invest. 120, 422-432 (2010).
7. Tieu, B. C., et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Invest. 119, 3637-3651 (2009).
8. Gräbner, R., et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J. Exp. Med. 206, 233-248 (2009).
9. Thaunat, O. & Nicoletti, A. Lymphoid neogenesis in chronic rejection. Curr. Opin. Organ Transplant. 13, 16-19 (2008).
10. Folkesson, M., et al. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb. Haemost. 98, 427-433 (2007). (Pubitemid 47250247)
11. Fontaine, V., et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am. J. Pathol. 164, 2077-2087 (2004). (Pubitemid 38669355)
12. Houard, X., Ollivier, V., Louedec, L., Michel, J. B. & Bäck, M. Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. FASEB J. 23, 1376-1383 (2009).
13. Eliason, J. L., et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112, 232-240 (2005). (Pubitemid 40982306)
14. Pagano, M. B., et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc. Natl Acad. Sci. USA 104, 2855-2860 (2007). (Pubitemid 46327969)
15. Sun, J., et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117, 3359-3368 (2007). (Pubitemid 350096992)
16. Norman, P. E., Davis, T. M., Le, M. T. & Golledge, J. Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect. Tissue Res. 48, 125-131 (2007). (Pubitemid 46860600)
17. Fontaine, V., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am. J. Pathol. 161, 1701-1710 (2002). (Pubitemid 35265529)
18. Lederle, F. A., et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 346, 1437-1444 (2002). (Pubitemid 34755711)
19. Houard, X., et al. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J. Pathol. 212, 20-28 (2007). (Pubitemid 46746286)
20. Sakalihasan, N., Limet, R. & Defawe, O. D. Abdominal aortic aneurysm. Lancet 365, 1577-1589 (2005). (Pubitemid 40615407)
21. Powell, J. T. & Brady, A. R. Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 24, 241-245 (2004). (Pubitemid 38197574)
22. Chaer, R. A., DeRubertis, B. G., Hynecek, R., Kent, K. C. & Faries, P. L. Models of abdominal aortic aneurysm: characterization and clinical applications. Vascular 14, 343-352 (2006). (Pubitemid 46579401)
23. Touat, Z., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am. J. Pathol. 168, 1022-1030 (2006). (Pubitemid 43327752)
24. Annambhotla, S., et al. Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J. Surg. 32, 976-986 (2008).
25. Pan, J. H., et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J. Vasc Surg. 37, 628-635 (2003).
26. Paraskevas, K. I., Mikhailidis, D. P. & Perrea, D. Experimental models of abdominal aortic aneurysms: an overview. Curr. Pharm. Des. 14, 325-337 (2008). (Pubitemid 351516857)
27. Houard, X., et al. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc. Res. 82, 532-541 (2009).
28. Vega de Céniga, M., et al. Search for serum biomarkers associated with abdominal aortic aneurysm growth-a pilot study. Eur. J. Vasc. Endovasc. Surg. 37, 297-299 (2009).
29. Lindholt, J. S., Ashton, H. A., Heickendorff, L. & Scott, R. A. Serum elastin peptides in the preoperative evaluation of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 22, 546-550 (2001). (Pubitemid 34030597)
30. Lindholt, J. S., Heickendorff, L., Vammen, S., Fasting, H. & Henneberg, E. W. Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 21, 235-240 (2001). (Pubitemid 32529981)
31. Juvonen, J., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 17, 2843-2847 (1997). (Pubitemid 28016030)
32. Treska, V., Topolcan, O. & Pecen, L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin. Chem. Lab. Med. 38, 1161-1164 (2000). (Pubitemid 32040864)
33. Golledge, J., et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 27, 655-660 (2007).
34. Anidjar, S., et al. Elastase-induced experimental aneurysms in rats. Circulation 82, 973-981 (1990). (Pubitemid 20316749)
35. Anidjar, S., Dobrin, P. B., Eichorst, M., Graham, G. P. & Chejfec, G. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms. J. Vasc. Surg. 16, 139-147 (1992).
36. Allaire, E., Guettier, C., Bruneval, P., Plissonnier, D. & Michel, J. B. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J. Vasc. Surg. 19, 446-456 (1994). (Pubitemid 24093978)
37. Martin-Ventura, J. L., et al. Proteomics in atherothrombosis: a future perspective. Expert Rev. Proteomics 4, 249-260 (2007). (Pubitemid 46588460)
38. Guerrier, L., et al. Reducing protein concentration range of biological samples using solid-phase ligand libraries. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 833, 33-40 (2006).
39. Wilmink, A. B., Hubbard, C. S. & Quick, C. R. Quality of the measurement of the infrarenal aortic diameter by ultrasound. J. Med. Screen. 4, 49-53 (1997). (Pubitemid 28270273)
40. Lindholt, J. S., Vammen, S., Juul, S., Henneberg, E. W. & Fasting, H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 17, 472-475 (1999). (Pubitemid 29296745)
41. Wilmink, A. B., Forshaw, M., Quick, C. R., Hubbard, C. S. & Day, N. E. Accuracy of serial screening for abdominal aortic aneurysms by ultrasound. J. Med. Screen. 9, 125-127 (2002). (Pubitemid 35205235)
42. Ellis, M., Powell, J. T. & Greenhalgh, R. M. Limitations of ultrasonography in surveillance of small abdominal aortic aneurysms. Br. J. Surg. 78, 614-616 (1991).
43. Ashton, H. A., et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360, 1531-1539 (2002). (Pubitemid 35356366)
44. Lindholt, J. S., Juul, S., Fasting, H. & Henneberg, E. W. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 330, 750 (2005).
45. Ashton, H. A., et al. Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms. Br. J. Surg. 94, 696-701 (2007). (Pubitemid 46910061)
46. Norman, P. E., et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 329, 1259 (2004).
47. Lederle, F. A., et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs cooperative study group. Ann. Intern. Med. 126, 441-449 (1997). (Pubitemid 27114472)
48. Scott, R. A., Wilson, N. M., Ashton, H. A. & Kay, D. N. Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study. Br. J. Surg. 82, 1066-1070 (1995).
49. Lindholt, J. S., Juul, S., Fasting, H. & Henneberg, E. W. Preliminary ten year results from a randomised single centre mass screening trial for abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 32, 608-614 (2006). (Pubitemid 44661066)
50. Lawrence-Brown, M. M., et al. Initial results of ultrasound screening for aneurysm of the abdominal aorta in Western Australia: relevance for endoluminal treatment of aneurysm disease. Cardiovasc. Surg. 9, 234-240 (2001). (Pubitemid 32381071)
51. Lindholt, J. S. & Norman, P. Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 36, 167-171 (2008). (Pubitemid 351952332)
52. Schlösser, F. J., et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J. Vasc. Surg. 47, 1127-1133 (2008).
53. Vardulaki, K. A., et al. Growth rates and risk of rupture of abdominal aortic aneurysms. Br. J. Surg. 85, 1674-1680 (1998). (Pubitemid 28548345)
54. Brady, A. R., Thompson, S. G., Fowkes, F. G., Greenhalgh, R. M. & Powell, J. T. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110, 16-21 (2004). (Pubitemid 38880128)
55. United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N. Engl. J. Med. 346, 1445-1452 (2002).
56. Chang, J. B., Stein, T. A., Liu, J. P. & Dunn, M. E. Risk factors associated with rapid growth of small abdominal aortic aneurysms. Surgery 121, 117-122 (1997). (Pubitemid 27091764)
57. Reed, W. W., Hallett, J. W. Jr, Damiano, M. A. & Ballard, D. J. Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm. Arch. Intern. Med. 157, 2064-2068 (1997). (Pubitemid 27431273)
58. Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113, e463-e654 (2006).
59. Nyhsen, C. M. & Elliott, S. T. Rapid assessment of abdominal aortic aneurysms by 3-dimensional ultrasonography. J. Ultrasound Med. 26, 223-226 (2007). (Pubitemid 46193342)
60. Leotta, D. F., et al. Measurement of abdominal aortic aneurysms with three-dimensional ultrasound imaging: preliminary report. J. Vasc. Surg. 33, 700-707 (2001). (Pubitemid 33586620)
61. Lindner, J. R., et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104, 2107-2112 (2001). (Pubitemid 33027054)
62. Villanueva, F. S. Molecular imaging of cardiovascular disease using ultrasound. J. Nucl. Cardiol. 15, 576-586 (2008). (Pubitemid 352044847)
63. Sakuta, A., et al. Delayed enhancement on computed tomography in abdominal aortic aneurysm wall. Heart Vessels 22, 79-87 (2007). (Pubitemid 46510546)
64. Roy, J., et al. Bleeding into the intraluminal thrombus in abdominal aortic aneurysms is associated with rupture. J. Vasc. Surg. 48, 1108-1113 (2008).
65. Summers, R. M., et al. Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia. Circulation 98, 509-518 (1998). (Pubitemid 28371248)
66. Kramer, C. M., et al. Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm. Circulation 109, 1016-1021 (2004). (Pubitemid 38282855)
67. Ludman, C. N., et al. Feasibility of using dynamic contrast-enhanced magnetic resonance angiography as the sole imaging modality prior to endovascular repair of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 19, 524-530 (2000).
68. van Herwaarden, J. A., et al. Aortic compliance following EVAR and the influence of different endografts: determination using dynamic MRA. J. Endovasc. Ther. 13, 406-414 (2006). (Pubitemid 44775218)
69. van Keulen, J. W., van Prehn, J., Prokop, M., Moll, F. L. & van Herwaarden, J. A. Dynamics of the aorta before and after endovascular aneurysm repair: a systematic review. Eur. J. Vasc. Endovasc. Surg. 38, 586-596 (2009).
70. Markl, M., et al. Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow. J. Magn. Reson. Imaging 25, 824-831 (2007). (Pubitemid 46516736)
71. Frydrychowicz, A., et al. Multidirectional flow analysis by cardiovascular magnetic resonance in aneurysm development following repair of aortic coarctation. J. Cardiovasc. Magn. Reson. 10, 30 (2008).
72. Rudd, J. H., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105, 2708-2711 (2002). (Pubitemid 34615139)
73. Sakalihasan, N., et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur. J. Vasc. Endovasc. Surg. 23, 431-436 (2002). (Pubitemid 41079425)
74. Truijers, M., Kurvers, H. A., Bredie, S. J., Oyen, W. J. & Blankensteijn, J. D. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J. Endovasc. Ther. 15, 462-467 (2008).
75. Xu, X. Y., et al. High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur. J. Vasc. Endovasc. Surg. 39, 295-301 (2010).
76. Klink, A., et al. Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. Arterioscler. Thromb. Vasc. Biol. 30, 403-410 (2010).
77. Sadat, U., Taviani, V., Patterson, A. J., Young, V. E., et al. Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms-a feasibility study. Eur. J. Vasc. Endovasc. Surg. doi:10.1016/j.ejvs.2010.08.022.
78. Cormode, D. P., Skajaa, T., Fayad, Z. A. & Mulder, W. J. Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol. 29, 992-1000 (2009).
79. Wilmink, T. B., Quick, C. R. & Day, N. E. The association between cigarette smoking and abdominal aortic aneurysms. J. Vasc. Surg. 30, 1099-1105 (1999).
80. Steinmetz, E. F., et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann. Surg. 241, 92-101 (2005). (Pubitemid 40040997)
81. Evans, J., Powell, J. T., Schwalbe, E., Loftus, I. M. & Thompson, M. M. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur. J. Vasc. Endovasc. Surg. 34, 302-303 (2007). (Pubitemid 47194427)
82. Schouten, O., et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur. J. Vasc. Endovasc. Surg. 32, 21-26 (2006). (Pubitemid 43842752)
83. Sukhija, R., Aronow, W. S., Sandhu, R., Kakar, P. & Babu, S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am. J. Cardiol. 97, 279-280 (2006). (Pubitemid 43139252)
84. Boucek, R. J., Gunja-Smith, Z., Noble, N. L. & Simpson, C. F. Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey. Biochem. Pharmacol. 32, 275-280 (1983). (Pubitemid 13184464)
85. Brophy, C. M., Tilson, J. E. & Tilson, M. D. Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse. J. Surg. Res. 46, 330-332 (1989). (Pubitemid 19124263)
86. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J. Vasc. Surg. 35, 72-79 (2002).
87. Leach, S. D., Toole, A. L., Stern, H., DeNatale, R. W. & Tilson, M. D. Effect of beta;-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch. Surg. 123, 606-609 (1988).
88. Gadowski, G. R., Pilcher, D. B. & Ricci, M. A. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J. Vasc. Surg. 19, 727-731 (1994). (Pubitemid 24137130)
89. Inoue, N., et al. Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. J. Atheroscler. Thromb. 16, 164-171 (2009).
90. Hackam, D. G., Thiruchelvam, D. & Redelmeier, D. A. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 368, 659-665 (2006). (Pubitemid 44226485)
91. Lederle, F. A. & Taylor, B. C. ACE inhibitors and aortic rupture. Lancet 368, 1571 (2006). (Pubitemid 44691907)
92. Petrinec, D., et al. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23, 336-346 (1996). (Pubitemid 26070722)
93. Prall, A. K., et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J. Vasc. Surg. 35, 923-929 (2002).
94. Baxter, B. T., et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg. 36, 1-12 (2002). (Pubitemid 41122881)
95. Curci, J. A., et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J. Vasc. Surg. 31, 325-342 (2000). (Pubitemid 30100042)
96. Golledge, J. & Powell, J. T. Medical management of abdominal aortic aneurysm. Eur. J. Vasc. Endovasc. Surg. 34, 267-273 (2007). (Pubitemid 47194418)
97. Lindholt, J. S., Ashton, H. A. & Scott, R. A. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J. Vasc. Surg. 34, 212-215 (2001). (Pubitemid 33661115)
98. Vammen, S., Lindholt, J. S., Ostergaard, L., Fasting, H. & Henneberg, E. W. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br. J. Surg. 88, 1066-1072 (2001). (Pubitemid 32868660)
99. Karlsson, L., Gnarpe, J., Bergqvist, D., Lindbäck, J. & Pärsson, H. The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms-a prospective randomized double-blind trial. J. Vasc. Surg. 50, 23-29 (2009).
100. Dai, J., Louedec, L., Philippe, M., Michel, J. B. & Houard, X. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. J. Vasc. Surg. 49, 719-727 (2009).
101. Malas, M. B. & Freischlag, J. A. Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry. Semin. Vasc. Surg. 23, 165-169 (2010).
102. Ouriel, K. The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms. J. Vasc. Surg. 49, 266-269 (2009).
103. Conrad, M. F., et al. Long-term durability of open abdominal aortic aneurysm repair. J. Vasc. Surg. 46, 669-675 (2007). (Pubitemid 47446111)
104. Adam, D. J., Fitridge, R. A. & Raptis, S. Late reintervention for aortic graft-related events and new aortoiliac disease after open abdominal aortic aneurysm repair in an Australian population. J. Vasc. Surg. 43, 701-705 (2006).
105. Vega de Céniga, M., et al. Long-term cardiovascular outcome after elective abdominal aortic aneurysm open repair. Ann. Vasc. Surg. 24, 655-662 (2010).
106. De Bruin, J. L., et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N. Engl. J. Med. 362, 1881-1889 (2010).
107. Greenhalgh, R. M., Brown, L. C., Kwong, G. P., Powell, J. T. & Thompson, S. G. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364, 843-848 (2004).
108. United Kingdom EVAR Trial Investigators. Endovascular versus open repair of abdominal aortic aneurysm. N. Engl. J. Med. 362, 1863-1871 (2010).
109. Yeung, J. J., Hernandez-Boussard, T. M., Song, T. K., Dalman, R. L. & Lee, J. T. Preoperative thrombus volume predicts sac regression after endovascular aneurysm repair. J. Endovasc. Ther. 16, 380-388 (2009).
110. The UK Small Aneurysm Trial Participants. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352, 1649-1655 (1998).
111. EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365, 2187-2192 (2005).
112. Ouriel, K. Randomized clinical trials of endovascular repair versus surveillance for treatment of small abdominal aortic aneurysms. J. Endovasc. Ther. 16 (Suppl. 1), I94-I105 (2009).
113. Mulder, W. J., et al. Multimodality nanotracers for cardiovascular applications. Nat. Clin. Pract. Cardiovasc. Med. 5 (Suppl. 2), S103-S111 (2008).
114. Broz, P., et al. Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin. J. Cardiovasc. Pharmacol. 51, 246-252 (2008). (Pubitemid 351450602)
115. Banciu, M., Metselaar, J. M., Schiffelers, R. M. & Storm, G. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia 10, 108-117 (2008). (Pubitemid 351240876)
116. Deux, J. F., et al. Aortic aneurysms in a rat model: in vivo MR imaging of endovascular cell therapy. Radiology 246, 185-192 (2008).
117. Serruys, P. W., et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373, 897-910 (2009).
118. Yoshimura, K., et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11, 1330-1338 (2005). (Pubitemid 41752914)